Annual Working Capital
$58.73 M
-$62.75 M-51.65%
31 March 2022
Summary:
Sio Gene Therapies annual working capital is currently $58.73 million, with the most recent change of -$62.75 million (-51.65%) on 31 March 2022. During the last 3 years, it has fallen by -$62.75 million (-51.65%).SIOX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$45.12 M
-$3.79 M-7.74%
31 December 2022
Summary:
Sio Gene Therapies quarterly working capital is currently $45.12 million, with the most recent change of -$3.79 million (-7.74%) on 31 December 2022.SIOX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -51.6% | -54.3% |
| 5 y5 years | -17.4% | +130.8% |
SIOX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -77.9% | -86.2% |
Sio Gene Therapies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $45.12 M(-7.7%) |
| Sept 2022 | - | $48.91 M(-2.2%) |
| June 2022 | - | $49.98 M(-14.9%) |
| Mar 2022 | $58.73 M(-51.7%) | $58.73 M(-21.6%) |
| Dec 2021 | - | $74.93 M(-24.0%) |
| Sept 2021 | - | $98.63 M(-11.4%) |
| June 2021 | - | $111.34 M(-8.4%) |
| Mar 2021 | $121.48 M(+127.6%) | $121.48 M(+37.9%) |
| Dec 2020 | - | $88.08 M(+46.1%) |
| Sept 2020 | - | $60.28 M(+23.5%) |
| June 2020 | - | $48.81 M(-8.6%) |
| Mar 2020 | $53.39 M(-24.9%) | $53.39 M(+1853.4%) |
| Dec 2019 | - | $2.73 M(-86.0%) |
| Sept 2019 | - | $19.55 M(-48.2%) |
| June 2019 | - | $37.71 M(-46.9%) |
| Mar 2019 | $71.08 M | $71.08 M(+53.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | - | $46.20 M(-2.4%) |
| Sept 2018 | - | $47.35 M(-19.0%) |
| June 2018 | - | $58.49 M(-47.6%) |
| Mar 2018 | $111.69 M(-35.6%) | $111.69 M(-26.0%) |
| Dec 2017 | - | $151.00 M(-25.2%) |
| Sept 2017 | - | $201.88 M(-21.0%) |
| June 2017 | - | $255.66 M(+47.4%) |
| Mar 2017 | $173.42 M(-34.9%) | $173.42 M(+4.5%) |
| Dec 2016 | - | $165.98 M(-19.3%) |
| Sept 2016 | - | $205.80 M(-14.2%) |
| June 2016 | - | $239.82 M(-10.0%) |
| Mar 2016 | $266.33 M(-9749.7%) | $266.33 M(-7.5%) |
| Dec 2015 | - | $287.93 M(-7.8%) |
| Sept 2015 | - | $312.14 M(-4.4%) |
| June 2015 | - | $326.53 M |
| Mar 2015 | -$2.76 M | - |
FAQ
- What is Sio Gene Therapies annual working capital?
- What is the all time high annual working capital for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly working capital?
- What is the all time high quarterly working capital for Sio Gene Therapies?
What is Sio Gene Therapies annual working capital?
The current annual working capital of SIOX is $58.73 M
What is the all time high annual working capital for Sio Gene Therapies?
Sio Gene Therapies all-time high annual working capital is $266.33 M
What is Sio Gene Therapies quarterly working capital?
The current quarterly working capital of SIOX is $45.12 M
What is the all time high quarterly working capital for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly working capital is $326.53 M